Avenue Biosciences technology collects data sets on how specific signal peptides impact specific protein targets.
The Kenya Times on MSN
Open University of Kenya opens over 60 job opportunities for lecturers and drivers: How to apply
The Open University of Kenya has announced 61 job opportunities for academic and administrative staff positions. In a notice ...
India Today on MSN
TVK chief Vijay appears before CBI in Delhi for Karur stampede probe | Tamil Nadu news
TVK chief and actor Vijay is set to appear before the Central Bureau of Investigation (CBI) in Delhi for questioning ...
The biotech sector has put up a strong recovery in 2025. The Nasdaq Biotechnology Index has risen 33.1% so far this year. The index bottomed out in April 2025 on potential imposition of steep tariffs, ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
The iShares Biotechnology ETF is up over 32% in six months on rate cut expectations and potential sector rotation. The State Street SPDR S&P Biotech ETF has surged 45% in six months but remains 27% ...
Dec 10 (Reuters) - French biotech company Abivax's (ABVX.PA), opens new tab shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly (LLY.N), opens new tab could make an ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Beverly biotech is working ...
The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from government-funded contracts and authorize the Trump administration to bar US ...
Swiss oncology powerhouse BeOne Medicines (ONC) has emerged as one of 2025's top performers in a sector often plagued by volatility. Year-to-date, ONC shares have rocketed 75%, outpacing many peers ...
If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...
Ritish Patnaik is bullish on Dallas becoming one of the top three bioscience cities in the country. “You can quote me on this,” he told D CEO Healthcare. “Dallas will be the third hub. San Francisco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results